Multiparametric Oncologic Hybrid Imaging: Machine Learning Challenges and Opportunities.
Thomas Küstner1, Tobias Hepp1, Ferdinand Seith2
1Medical Image and Data Analysis (MIDAS.lab), Department of Diagnostic and Interventional Radiology, University Hospitals Tubingen, Germany.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|February 25, 2022
Summary
Machine learning (ML) offers significant advancements for healthcare data analysis, particularly in radiology and nuclear medicine. This technology promises faster image acquisition, improved quality, and enhanced decision-making through hybrid imaging analysis.
Area of Science:
- Integrates machine learning (ML) into advanced medical imaging techniques.
- Focuses on the intersection of ML, hybrid imaging (MRI, CT, PET), and oncology.
Background:
- Machine learning (ML) is a pivotal technology for future healthcare data analysis.
- Diagnostic radiology and nuclear medicine are poised for substantial benefits from ML integration.
Purpose of the Study:
- To review the fundamentals of ML in the context of medical imaging.
- To explore ML applications in hybrid imaging modalities like MRI, CT, and PET.
- To discuss challenges and future directions for ML as a clinical diagnostic tool.
Main Methods:
- Describes the basic principles of machine learning (ML).
- Presents current ML approaches applied to hybrid imaging (MRI, CT, PET).
- Analyzes the specific challenges and future steps for clinical ML implementation.
Main Results:
- ML enhances image acquisition, improving quality and reducing artifacts.
- PET imaging benefits include reduced radiation exposure and improved attenuation correction.
- ML supports oncology decision-making via multiparametric hybrid imaging and biomarker development.
Conclusions:
- Machine learning (ML) presents a viable clinical solution for hybrid imaging reconstruction, processing, and analysis.
- ML holds significant potential for advancing diagnostic capabilities in multiparametric oncologic hybrid imaging.
